NIH-funded research R01 grant

Protecting the Mouth from Radiation Side Effects

Official title: Radioprotective effect of p53 against oral mucositis

Funded at Duke University · NIH-11111172 · Data updated 2026-11-12

This project looks for ways to protect the mouth from painful sores that can happen during radiation treatment for head and neck cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 7, 2023
Project endJune 30, 2028
Funding year2025
Award (this year)$509,544
NIH project number5R01DE033404-03
Project IDNIH-11111172 on NIH RePORTER

Who could benefit from this research

Could help

Patients undergoing radiation therapy for head and neck squamous cell carcinoma who experience or are at risk of developing oral mucositis could potentially benefit from future therapies developed from this research.

Less likely to help

Patients not receiving radiation therapy for head and neck cancer would not directly benefit from this specific research.

What this research studies

Head and neck cancer treatments often involve radiation, which can cause severe mouth sores called oral mucositis. These sores can make it hard to eat, lead to pain, and sometimes interrupt cancer treatment. This project aims to understand how a protein called p53, which is important for cell health, might help protect healthy mouth tissues from radiation damage. By learning more about p53's role, researchers hope to develop new ways to prevent or reduce these painful side effects for patients.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that prevent or lessen severe mouth sores for patients undergoing radiation therapy for head and neck cancer.

How similar studies have gone: Current treatment options for radiation-induced oral mucositis are limited, indicating this approach explores a novel strategy to widen the therapeutic window of head and neck radiation therapy.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Lee, Chang-Lung — Duke University
  • Study coordinator: Lee, Chang-Lung

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.